Page last updated: 2024-08-23

mifepristone and Placenta, Retained

mifepristone has been researched along with Placenta, Retained in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bai, H; Cui, R; Lu, J; Zhang, Z1
Heikinheimo, O; Mentula, M1
Willems, FE1
Li, Q; Liu, M; Mu, YL; Yang, ZL; Yin, FB1
Hahlin, M; Nielsen, S; Platz-Christensen, J1

Trials

2 trial(s) available for mifepristone and Placenta, Retained

ArticleYear
Risk factors of surgical evacuation following second-trimester medical termination of pregnancy.
    Contraception, 2012, Volume: 86, Issue:2

    Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Eugenic; Abortion, Therapeutic; Adolescent; Adult; Dilatation and Curettage; Dose-Response Relationship, Drug; Female; Finland; Follow-Up Studies; Hospitals, University; Humans; Maternal Age; Mifepristone; Misoprostol; Placenta, Retained; Pregnancy; Pregnancy Trimester, Second; Risk Factors; Time Factors; Young Adult

2012
Randomised trial comparing expectant with medical management for first trimester miscarriages.
    British journal of obstetrics and gynaecology, 1999, Volume: 106, Issue:8

    Topics: Abortifacient Agents, Steroidal; Abortion, Spontaneous; Adult; Ambulatory Care; Chorionic Gonadotropin; Female; Humans; Length of Stay; Mifepristone; Pain; Placenta, Retained; Pregnancy; Pregnancy Trimester, First; Progesterone

1999

Other Studies

3 other study(ies) available for mifepristone and Placenta, Retained

ArticleYear
The Feasibility of Conservative Management for Morbidly Adherent Placenta Accidentally Encountered after Vaginal Delivery.
    Gynecologic and obstetric investigation, 2017, Volume: 82, Issue:5

    Topics: Abortifacient Agents; Adult; Balloon Occlusion; Blood Transfusion; Conservative Treatment; Delivery, Obstetric; Drugs, Chinese Herbal; Feasibility Studies; Female; Humans; Hysterectomy; Methotrexate; Mifepristone; Placenta; Placenta Accreta; Placenta, Retained; Postpartum Hemorrhage; Pregnancy; Retrospective Studies; Uterine Artery Embolization; Vagina

2017
[Pregnancy termination in the second trimester with vaginally administered dinoprostone followed by intravenous sulprostone, for the indication 'foetal congenital defects'; results of a retrospective study].
    Nederlands tijdschrift voor geneeskunde, 2004, Aug-14, Volume: 148, Issue:33

    Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Dinoprostone; Female; Humans; Mifepristone; Misoprostol; Placenta, Retained; Pregnancy

2004
[Clinical value of transcervical resection under hysteroscope for placental remnants].
    Zhonghua fu chan ke za zhi, 2007, Volume: 42, Issue:8

    Topics: Abortifacient Agents, Nonsteroidal; Adult; Chorionic Gonadotropin, beta Subunit, Human; Combined Modality Therapy; Electrosurgery; Female; Humans; Hysteroscopy; Methotrexate; Mifepristone; Misoprostol; Placenta, Retained; Pregnancy; Retrospective Studies; Treatment Outcome; Ultrasonography

2007